Skip to search formSkip to main contentSkip to account menu

CD19L-sTRAIL fusion protein, human

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
OBJECTIVE To investigate the inhibitory effect of MenSC-sTRAIL on the apoptosis of A549 cells of lung cancer in a nude mouse… 
2015
2015
Mesenchymal stem cells (MSCs) are believed to be a potential vehicle delivering antitumor agents for their tumor-homing capacity… 
2015
2015
Patients with B cell precursor acute lymphoblastic leukemia (BPL) respond well to chemotherapy at initial diagnosis; however… 
2013
2013
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can selectively kill tumor cells and enhance therapy in vivo… 
Highly Cited
2013
Highly Cited
2013
Mesenchymal stem cells (MSCs) are an attractive candidate for cell-based therapy. We have designed a promising double-target… 
2008
2008
OBJECTIVE To evaluate the impact of the recombined adeno-associated virus encoding soluble tumor necrosis factor related… 
2006
2006
Tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) induces cell death in various tumor cells, but relatively spares…